| Q37447460 | 3-(1,3-Di-phenyl-propan-2-yl)-4-methyl-6-phenyl-isoxazolo[3,4-d]pyridazin-7(6H)-one |
| Q30414092 | Blocking metabotropic glutamate receptor subtype 7 (mGlu7) via the Venus flytrap domain (VFTD) inhibits amygdala plasticity, stress, and anxiety-related behavior |
| Q33520184 | Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate receptor 7 |
| Q53015251 | Development of PET and SPECT probes for glutamate receptors. |
| Q37355350 | Effects of a metabotropic glutamate receptor subtype 7 negative allosteric modulator in the periaqueductal grey on pain responses and rostral ventromedial medulla cell activity in rat. |
| Q43225284 | Improved synthesis of 3-aryl isoxazoles containing fused aromatic rings |
| Q38865953 | Metabotropic Glutamate Receptor 7: From Synaptic Function to Therapeutic Implications |
| Q37183072 | Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors |
| Q92431288 | Progress toward allosteric ligands of metabotropic glutamate 7 (mGlu7) receptor: 2008-present |
| Q43193327 | Selective Negative Allosteric Modulation Of Metabotropic Glutamate Receptors – A Structural Perspective of Ligands and Mutants |
| Q38185074 | Supraspinal metabotropic glutamate receptors: a target for pain relief and beyond |
| Q37116035 | Synthesis and evaluation of [11C]MMPIP as a potential radioligand for imaging of metabotropic glutamate 7 receptor in the brain |
| Q37172873 | The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders |
| Q89689611 | VU6010608, a Novel mGlu7 NAM from a Series of N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamides |